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Abstract: 
 
Heart failure due to metabolic derangements is not common in clinical practice. However, 
outcome is usually positive given that the precipitating factor is recognized and treatment is 
initiated in a timely fashion. We report an unusual case of reduced left ventricular systolic 
function in the setting of hypocalcemia in a patient without known structural heart disease. Delay 
in seeking appropriate medical attention has culminated in cardiac dysfunction that was 
favorably altered with correction of hypocalcemia.  
 
Keywords:  Cardiomyopathy, hypothyroidism, hypocalcemia, hypoparathyroidism 
 
Introduction: 
 
Most patients with cardiomyopathy have a poor prognosis due to progressive and irreversible 
myocardial dysfunction. Although some causes of cardiomyopathy are well known, such as toxic 
substances or viral infections, rarely, is there a reversible cause identified and the etiology is 
deemed idiopathic.  The role of calcium in myocardial excitation contraction coupling has been 
well described but hypocalcemic cardiomyopathy due to hypoparathyroidism is an infrequently 
encountered condition. It is usually refractory to conventional treatment but responds favorably 
to restoration of normocalcemia. (1) 
 
Cardiac dysfunction secondary to metabolic derangements should be considered in the 
differential diagnosis of heart failure in previously healthy patients who do not respond 
adequately to the usual treatment. Prompt recognition of the provoking factor is important since 
the disease process is potentially reversible. We report a case and discuss the mechanism of acute 
cardiomyopathy associated with hypocalcemia. 
 
Case Report: 
 
A 57 year old previously healthy white woman was found at home by her daughter having 
convulsions. A CT-scan of the head at a local emergency department (ED) was obtained with 
normal results. She was transferred to our center because of elevated cardiac enzymes. 
Subsequently she regained consciousness, reporting chest pain that was relieved by short acting 
nitroglycerin. She denied shortness of breath but reported dry cough and fatigue.   The patient 
appeared distressed but was alert and oriented. Her blood pressure (BP) was 98/47 mmHg, heart 
rate regular 97 beats per minute, respiratory rate 28 per minute, temperature 96°F and oxygen 
saturation 92% on 4 liters of oxygen by nasal canula. Physical examination showed faint S1 and 
S2 without murmur; bilateral fine crepitations in all lung fields, and pitting lower limb edema. 
Chvostek's and Trousseau's sign (carpopedal spasm) were not elicited. The patient’s past medical 
history was insignificant; no history of neck surgery or radiation as a reason for hypothyroidism 
or hypoparathyroidism, there was no history of alcohol abuse that may result in systolic 
dysfunction.  Furthermore, tachycardia mediated cardiomyopathy was ruled out since there was 
no history of arrhythmia and none was identified during her hospital stay while she was on 
telemetry monitoring. Iron study performed to screen for hemochromatosis is within normal. 
There was no known family history of endocrine disorders. 
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Initial workup in the ED revealed a calcium level of 5mg/dl (refer to Table 1 for laboratory 
results). A 12 lead electrocardiogram (EKG) (Figure 1) demonstrated T-wave inversion along 
with a prolonged QT interval (QTc= 0.693 sec using Bazett’s formula). Urine drug screen 
including cocaine was negative. 
 
Table 1: Laboratory results 
Laboratory   Value Range 
Calcium 5 mg/dl 8.5-10.5 mg/dl 
Ionized calcium 0.65 mmol/l 1.12-1.38 mmol/l 
Phosphorus 8.2 mg/dl 2.5-4.5 mg/dl 
Magnesium 1.7 mg/dl 1.6-2.4 mg/dl 
Parathyroid hormone 2.5 pg/ml (8-97 pg/ml) 
25, Hydroxy vitamin D 8 ng/ml (32-100ng/ml) 
TSH 21.48 miliU/L 0.370-4.420  miliU/L 
Free T4 0.62 ng/dl 0.75-2 
Troponin 9.3 0.0-0.5 
Total CK 13983 55-170 
CKMB 77.1 0.0-5 
Myoglobin >1000 0-110 
Creatinine 1.6 mg/dl 0.7-1.4 
BUN 19mg/dl 7-21 mg/dl 
 
 
 
Figure 1: Electrocardiogram demonstrating prolonged corrected QT interval (QTc= 0.693  
second using Bazett’s formula) and T-wave inversion in leads I and AVL. 
 
 
Her chest X-ray showed pulmonary edema (Figure 2). Echocardiogram demonstrated a globally 
hypokinetic left ventricle with severely depressed left ventricular ejection fraction of 25-30% 
without evidence of left ventricular hypertrophy or significant valvular lesions.  Subsequent 
cardiac catheterization revealed no angiographic evidence of obstructive coronary artery disease.  
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Figure 2:  Chest X-ray demonstrating bilateral interstitial infiltrate consistent with   
                  pulmonary edema. 
 
The patient initially received a single dose of intravenous calcium gluconate of 1000 milligrams 
given slowly to reverse the acute effects of hypocalcemia including seizures. The levels of 
ionized calcium were closely followed and a dose of calcium chloride 1000 milligrams was 
subsequently administered via central line resulting in the correction of serum calcium. The 
patient’s symptoms started to subside, hemodynamic status improved and EKG changes resolved 
after serum calcium was normalized (Figure 3).  Endocrinology service was consulted to provide 
advice on treating hypothyroidism and hypoparathyroidism. The patient was started on oral 
supplementation of calcium carbonate and vitamin D (1,25-dihydroxycholecalciferol) and was 
also started on thyroid replacement therapy. She remained asymptomatic and was discharged 
home in a stable condition. Unfortunately, the patient was lost to cardiology follow-up, and her 
long-term clinical course is unknown. 
 
 
Figure 3: Electrocardiogram demonstrating normalization of corrected QT interval (QTc= 0.41  
      second using Bazett’s formula) and resolution of previously noted T wave inversion. 
 
Discussion: 
 
This unique case demonstrates acute cardiomyopathy precipitated by metabolic derangement in 
the absence of other obvious etiologies. 
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It is well established that calcium ions play a central role in myocardial excitation contraction 
coupling (Figure 4) and myocardial relaxation. (2) Once the intracellular concentration of 
calcium increases, calcium ions bind to the protein troponin which initiates contraction by 
allowing the contractile proteins, myosin and actin, to associate through cross-bridge formation. 
An inward flux of extracellular calcium ions through L-type calcium channels a voltage 
dependent calcium channel, sustains the depolarization of cardiac muscle cells for a longer 
duration. (2) Therefore, hypocalcemia may cause cardiac dysfunction that usually does not 
respond to positive inotropic and diuretic therapies. While moderate reduction of serum calcium 
for a limited period of time may not result in a clinically appreciable decrease in myocardial 
function, it appears that profound and prolonged hypocalcemia may result in secondary 
cardiomyopathy manifested clinically by congestive heart failure that is responsive only to 
normalization of serum calcium. (3)  Several cases have been reported in medical literature 
demonstrating the restoration of cardiac function after correction of serum calcium levels (Table 
2). 
 
 
Figure 4: The role of calcium in systole and diastole at cellular level. 1) Calcium enters via L- 
                 type calcium channels following depolarization. 2) Entering calcium stimulates the  
                 release of calcium via Ryanodine receptors on sarcoplasmic reticulum. 3) Calcium  
                 interacts with Troponin C initiating contraction (systole). 4) Calcium uptake via   
                 SERCA results in relaxation (diastole). 5) Calcium is extruded outside myocyte via   
                 Na+/Ca2+ exchanger (17, 18). 
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Table 2: Case reports of hypocalcemic cardiomyopathy illustrating the impact of hypoclacemia   
               on cardiac function and the improvement in systolic and/or diastolic function with  
               normocalcemia. 
Author Patient’s 
age 
(years) 
Clinical 
Presentation 
Calcium 
level 
(mg/dl) 
EF Diagnosis Response 
 
Ozerka
n et al. 
(9) 
40 CHF, 
NHYA class 
III 
6.3 25% Primary 
hypoparathyroidism 
LVEF 
improved 
Lam et 
al. (10) 
37 CHF 2.9 Systolic 
and 
diastolic 
dysfunc-
tion 
Iatrogenic 
hyoparathyroidism 
Persistence 
of systolic 
and 
diastolic 
dysfunction 
Behagh
el et al 
(11) 
76 CHF 4.8 36% Iatrogenic 
hypoparathyroidism 
Normaliza-
tion of 
systolic 
function 
after 2 
months 
Sung et 
al. (12) 
57 CHF, 
NHYA class 
III 
5.16 37% Iatrogenic 
hypoparathyroidism 
EF 
improved 
to 61% 
Ari H 
et al. 
(13) 
27 CHF 2.9 20-25% Vitamin D resistant 
rickets 
EF 
improved 
to 55% 
Avsar 
et al. 
(14) 
40 CHF 3.5 25% Iatrogenic 
hypoparathyroidism 
EF 
improved 
to normal 
Kini et 
al. (15) 
30 CHF 3.03 20% Primary 
hypoparathyroidism 
Clinically 
improved 
but EF at 
35% after 
40 months 
Fisher 
et al 
(16) 
38 Atypical 
chest pain, 
ischemic 
EKG 
changes 
6.8 37% Iatrogenic 
hypoparathyroidism 
Normaliza-
tion of 
LVEF after 
3 months 
 
 
Our patient had EKG changes that were resolved after correction of the serum calcium. The EKG 
changes could be explained by coronary artery spasm, known to occur with hypomagnesemia, 
which in turn is often associated with hypocalcemia. (4) 
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The deficiency of thyroid hormones can be also connected with a range of metabolic and 
hemodynamic changes that can contribute to the genesis of heart failure.  The major 
cardiovascular changes that occur in hypothyroidism include decreased cardiac contractility, 
reduced heart rate, and increased peripheral vascular resistance. (5, 6) 
 
The history and laboratory findings in this patient suggest that hypocalcemia, secondary to 
hypoparathyroidism, in the presence of unrecognized and untreated hypothyroidism have 
predisposed to acute decompensation of heart failure. Attributing acute myocardial dysfunction 
to hypocalcemia in this case is justified by several explanations. First, the patient demonstrated 
rapid clinical improvement upon administration of calcium without the use of inotropic agents or 
diuretics. Second, supplementation with thyroid replacement therapy does not usually result in 
prompt reversal of metabolic events. Third, although the most common reason for impaired 
cardiac function is ischemic heart disease, the presence of normal coronary angiogram excluded 
significant atherosclerosis as the underlying cause. Fourth, there was an absence of usual 
etiologies of systolic dysfunction including alcoholism, long standing tachycardia, cocaine abuse 
and structural heart disease. 
 
Symptomatic patients presenting with neuromuscular irritability secondary to hypocalcaemia or 
asymptomatic patients with corrected serum calcium of less than 7.5 mg/dl are treated with 
intravenous calcium gluconate. (7) Calcium gluconate (10 ml of 10%) can be slowly infused 
over 10-20 minutes. (7)  It is preferred over calcium chloride which may cause local irritation. 
Calcium showed not to be infused rapidly due to risk of dysarrhythmias and cardiac arrest. (8) 
Infusion of calcium can be repeated until symptoms have resolved. Oral calcium replacement 
should be given concurrently and a vitamin D analogue added if parathyroid hormone is deficient 
(7) as in this case. 
 
Conclusion: 
 
Hypocalcemia secondary to hypoparathyroidism is a rare cause of heart failure in adults, and is 
curable after administration of calcium. It is can be overlooked, although easily diagnosed and 
treated. 
 
It is important to consider metabolic derangement in patients with symptoms of heart failure of 
unidentified cause, as it is potentially reversible. 
 
 
 
 
 
 
 
 
 
 
 
 
10
Darrat et al.: Cardiomyopathy secondary to endocrine dysfunction
Published by Marshall University's Joan C. Edwards School of Medicine, 2016
References: 
 
1. Altunbaş H, Balci MK, Yazicioğlu G, Semiz E, Ozbilim G, Karayalçin U. Hypocalcemic cardiomyopathy 
due to untreated hypoparathyroidism. Hormone Research 2003; 59(4):201-4. 
2. Endo M. (1977). "Calcium release from the sarcoplasmic reticulum." Physiol Rev 57 (1): 71–108. 
3. Boshour T, Basha HS, Cheng TO: Hypocalcemic cardiomyopathy. Chest 1980; 78:663-65. 
4. Khardori R, Cohen B, Taylor D, Soler NG.   Electrocardiographic finding simulating acute myocardial 
infarction in a compound metabolic aberration. Am J Med 1985; 78:529–32. 
5. Taddei, S, Caraccio, N, Virdis A. Impaired endothelium-dependent vasodilatation in subclinical 
hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003; 88:3731. 
6. Klein, I, Ojamaa, K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344:501. 
7. Thakker RV. Parathyroid disorders and diseases altering calcium metabolism. In: Warrall D, Cox T, Firth J, 
Benz E, eds. Oxford textbook of medicine 4th ed. Oxford: Oxford University Press, 2003. 
8. Tohme, JF, Bilezikian, JP. Diagnosis and treatment of hypocalcemic emergencies. The Endocrinologist. 
1996; 6:10.  
9. Ozerkan F, Güngör H, Zoghi M, Nalbantgil S. Cardiac failure secondary to idiopathic hypoparathyroidism: 
a case report. Turk Kardiyol Dern Ars 2009 Jan;37(1):53-6. 
10. Lam J, Maragaño P, Lépez B, Vásquez L. Hypocalcemic cardiomyopathy secondary to hypoparathyroidism 
after a thyroidectomy: report of one case. Rev Med Chil 2007 Mar;135(3):359-64.  
11. Behaghel A, Donal E. Hypocalcaemia-induced transient dilated cardiomyopathy in elderly: a case report. 
Eur J Echocardiogr 2011 Oct;12(10):E38. 
12. Sung JK, Kim JY, Ryu DW, Lee JW, Youn YJ, Yoo BS et al. A case of hypocalcemia-induced dilated 
cardiomyopathy. J Cardiovasc Ultrasound 2010 Mar;18(1):25-7.  
13. Ari H, Ari S, Koca V, Bozat T. A rare cause of reversible dilated cardiomyopathy: hypocalcemia. Turk 
Kardiyol Dern Ars 2009 Jun;37(4):266-8. 
14. Avsar A, Dogan A, Tavli T. A rare cause of reversible dilated cardiomyopathy: hypocalcemia. 
Echocardiography 2004 Oct;21(7):609-12. 
15. Kini SM, Pednekar SJ, Nabar ST, Varthakavi P. A reversible form of cardiomyopathy. J Postgrad Med 
2003 Jan-Mar;49(1):85-7. 
16. Fisher NG, Armitage A, McGonigle RJ, Gilbert TJ. Hypocalcaemic Cardiomyopathy; the relationship 
between myocardial damage, left ventricular function, calcium and ECG changes in a patient with 
idiopathic hypocalcaemia. Eur J Heart Fail 2001 Jun;3(3):373-6. 
17. Sandow A. Excitation-Contraction Coupling in Muscular Response. Yale J Biol Med 25 (3): 176–201. Yale 
J Biol Med 1952 December; 25(3): 176–201. 
18. Lionel H. Opie, Gerd Hasenfuss. Mechanisms of Cardiac Contraction and Relaxation. In: Robert O. 
Bonow, Douglas L. Mann, Douglas P. Zipes, Peter Libby. Braunwald’s Heart Disease. Philadelphia: 
Elsevier Saunders; 2012. 
 
11
Marshall Journal of Medicine, Vol. 2 [2016], Iss. 1, Art. 3
https://mds.marshall.edu/mjm/vol2/iss1/3
DOI: http://dx.doi.org/10.18590/mjm.2016.vol2.iss1.3
